Emergent BioSolutions (EBS) Issues 2022 Guidance; Reports Prelim FY21 Results
Go back to Emergent BioSolutions (EBS) Issues 2022 Guidance; Reports Prelim FY21 Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 5.97 +0.33 (5.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.64 | 52 Week High | $44.38 | |||
| Open | $5.56 | 52 Week Low | $24.47 | |||
| Day High | $6.00 | P/E | 298.50 | |||
| Day Low | $5.55 | EPS | $0.02 | |||
| Volume | 1,165,758 | |||||

